标题
New horizons in hepatitis C antiviral therapy with direct-acting antivirals
作者
关键词
-
出版物
HEPATOLOGY
Volume 58, Issue 1, Pages 428-438
出版商
Wiley
发表日期
2013-03-07
DOI
10.1002/hep.26371
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- New Protease Inhibitors for the Treatment of Chronic Hepatitis C
- (2013) Shan Liu et al. ANNALS OF INTERNAL MEDICINE
- Analysis of hepatitis C virus resistance to silibininin vitroandin vivopoints to a novel mechanism involving nonstructural protein 4B
- (2013) Katharina Esser-Nobis et al. HEPATOLOGY
- The antimalarial ferroquine is an inhibitor of hepatitis C virus
- (2013) Thibaut Vausselin et al. HEPATOLOGY
- Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
- (2013) Edward J. Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)
- (2012) Fiona McPhee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants
- (2012) Vincenzo Summa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genotype and Subtype Profiling of PSI-7977 as a Nucleotide Inhibitor of Hepatitis C Virus
- (2012) Angela M. Lam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Rapid and sharp decline in hepatitis C virus upon monotherapy with NS3 protease inhibitor, ACH-1625
- (2012) Atul Agarwal et al. ANTIVIRAL THERAPY
- Second generation direct antivirals and the way to interferon-free regimens in chronic HCV
- (2012) Heather Lewis et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- The role of resistance in HCV treatment
- (2012) Johannes Vermehren et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Discovery of GS-9451: An acid inhibitor of the hepatitis C virus NS3/4A protease
- (2012) X. Christopher Sheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Boceprevir: A Protease Inhibitor for the Treatment of Hepatitis C
- (2012) Mei H. Chang et al. CLINICAL THERAPEUTICS
- TMC435 for the treatment of chronic hepatitisC
- (2012) Sudeep Tanwar et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Telaprevir for the treatment of hepatitis C
- (2012) Nicole Forestier et al. EXPERT OPINION ON PHARMACOTHERAPY
- Is Hepatitis Virus Resistance to Antiviral Drugs a Threat?
- (2012) Jean–Michel Pawlotsky GASTROENTEROLOGY
- New protease inhibitors and direct-acting antivirals for hepatitis C: interferon's long goodbye: Table 1
- (2012) Geoffrey Dusheiko et al. GUT
- Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C
- (2012) Calogero Cammà et al. HEPATOLOGY
- Impact of a baseline polymorphism on the emergence of resistance to the hepatitis C virus nonstructural protein 5a replication complex inhibitor, BMS-790052
- (2012) Jin-Hua Sun et al. HEPATOLOGY
- Low rates of naturally occurring resistant variants to the NS5A inhibitor daclatasvir in HCV-1 null responders
- (2012) Enrico Galmozzi et al. HEPATOLOGY
- Antiviral strategies in hepatitis C virus infection
- (2012) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- 1399 12-WEEK INTERFERON-FREE REGIMEN OF ABT-450/R +ABT-333 +RIBAVIRIN ACHIEVED SVR12 IN MORE THAN 90% OF TREATMENT-NAIVE HCV GENOTYPE-1-INFECTED SUBJECTS AND 47% OF PREVIOUS NON-RESPONDERS
- (2012) F. Poordad et al. JOURNAL OF HEPATOLOGY
- Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin
- (2012) Dominique Larrey et al. JOURNAL OF HEPATOLOGY
- Hepatitis C therapy in non-genotype 1 patients: the near future
- (2012) C. Wartelle-Bladou et al. JOURNAL OF VIRAL HEPATITIS
- Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents
- (2012) F. Poordad et al. JOURNAL OF VIRAL HEPATITIS
- Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation
- (2012) Robert J. Fontana et al. LIVER TRANSPLANTATION
- Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
- (2012) Anna S. Lok et al. NEW ENGLAND JOURNAL OF MEDICINE
- The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function
- (2012) Christy M. Hebner et al. PLoS One
- Small molecule inhibitors of the hepatitis C virus-encoded NS5A protein
- (2012) Oscar Belda et al. VIRUS RESEARCH
- The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
- (2012) Keith P. Romano et al. PLoS Pathogens
- New opportunities in anti-hepatitis C virus drug discovery: Targeting NS4B
- (2011) Roopa Rai et al. ANTIVIRAL RESEARCH
- Identification of a novel resistance mutation for benzimidazole inhibitors of the HCV RNA-dependent RNA polymerase
- (2011) Leen Delang et al. ANTIVIRAL RESEARCH
- Discovery of GS-9256: A novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activity
- (2011) X. Christopher Sheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Mixing and Matching Drugs: What Makes Sense?
- (2011) Tania M. Welzel et al. Clinics in Liver Disease
- Second-wave Protease Inhibitors: Choosing an Heir
- (2011) Sandra Ciesek et al. Clinics in Liver Disease
- The NS5A Replication Complex Inhibitors: Difference Makers?
- (2011) Robert G. Gish et al. Clinics in Liver Disease
- Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
- (2011) Robert A. Fridell et al. HEPATOLOGY
- Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease
- (2010) P. W. White et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- New Insights into Structure and Replication of the Hepatitis C Virus and Clinical Implications
- (2010) Marion Poenisch et al. SEMINARS IN LIVER DISEASE
- In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor
- (2009) T.-I Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MK-7009, a Potent and Selective Inhibitor of Hepatitis C Virus NS3/4A Protease
- (2009) N. J. Liverton et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synthesis and SAR of piperazinyl-N-phenylbenzamides as inhibitors of hepatitis C virus RNA replication in cell culture
- (2009) Immacolata Conte et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Resistance to Direct Antiviral Agents in Patients With Hepatitis C Virus Infection
- (2009) Christoph Sarrazin et al. GASTROENTEROLOGY
- Identification of Hepatitis C Virus NS5A Inhibitors
- (2009) J. A. Lemm et al. JOURNAL OF VIROLOGY
- Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)
- (2008) S. D. Seiwert et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Molecular Mechanism of Hepatitis C Virus Replicon Variants with Reduced Susceptibility to a Benzofuran Inhibitor, HCV-796
- (2008) A. Y. M. Howe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Hepatitis C Virus Replicon Presents a Higher Barrier to Resistance to Nucleoside Analogs than to Nonnucleoside Polymerase or Protease Inhibitors
- (2008) M. F. McCown et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity In Vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus
- (2008) Norman M. Kneteman et al. HEPATOLOGY
- Treatment predictors of a sustained virologic response in hepatitis B and C
- (2008) Annika Kau et al. JOURNAL OF HEPATOLOGY
- Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis
- (2008) Shirit Einav et al. NATURE BIOTECHNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search